These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 27688110)
1. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome. Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and molecular spectrum of spindle cell and sclerosing rhabdomyosarcomas in the head and neck region. Wang Y; Li J; Tian Z; Zhu Y Int J Clin Exp Pathol; 2018; 11(7):3436-3444. PubMed ID: 31949721 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience. Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515 [TBL] [Abstract][Full Text] [Related]
4. MYOD1 as a prognostic indicator in rhabdomyosarcoma. Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590 [TBL] [Abstract][Full Text] [Related]
5. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas. Rekhi B; Singhvi T APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567 [TBL] [Abstract][Full Text] [Related]
6. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee. Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612 [TBL] [Abstract][Full Text] [Related]
7. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases. Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226 [TBL] [Abstract][Full Text] [Related]
8. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases. Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891 [TBL] [Abstract][Full Text] [Related]
9. Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Gallego S; Zanetti I; Orbach D; Ranchère D; Shipley J; Zin A; Bergeron C; de Salvo GL; Chisholm J; Ferrari A; Jenney M; Mandeville HC; Rogers T; Merks JHM; Mudry P; Glosli H; Milano GM; Ferman S; Bisogno G; Cancer; 2018 Aug; 124(15):3201-3209. PubMed ID: 29797665 [TBL] [Abstract][Full Text] [Related]
10. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma. Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044 [TBL] [Abstract][Full Text] [Related]
12. Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children's Oncology Group. Chiles MC; Parham DM; Qualman SJ; Teot LA; Bridge JA; Ullrich F; Barr FG; Meyer WH; Pediatr Dev Pathol; 2004; 7(6):583-94. PubMed ID: 15630526 [TBL] [Abstract][Full Text] [Related]
13. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation. Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411 [TBL] [Abstract][Full Text] [Related]
14. Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis. Gallagher KPD; van Heerden W; Said-Al-Naief N; Carlos R; Arboleda LPA; Rodrigues-Fernandes CI; Araújo ALD; Fonseca FP; Pontes HAR; Innocentini LMAR; Romañach MJ; Vargas PA; Lopes MA; Santos-Silva AR; Khurram SA Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):354-366. PubMed ID: 35840496 [TBL] [Abstract][Full Text] [Related]
16. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification. de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267 [TBL] [Abstract][Full Text] [Related]
17. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Folpe AL; McKenney JK; Bridge JA; Weiss SW Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574 [TBL] [Abstract][Full Text] [Related]
18. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843 [TBL] [Abstract][Full Text] [Related]
19. Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis. Walther C; Mayrhofer M; Nilsson J; Hofvander J; Jonson T; Mandahl N; Øra I; Gisselsson D; Mertens F Genes Chromosomes Cancer; 2016 Jan; 55(1):3-15. PubMed ID: 26482321 [TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]